Dr. Miller: Phakic Eyes


OUR COLLEAGUE: Daniel M. Miller, MD, PhD — Cincinnati, OH

"This phakic patient with cataracts was concerned about frequent injections for her DME. I chose ILUVIEN for this patient and her edema improved, and after cataract surgery she is seeing great."
— Daniel M. Miller, MD, PhD

Above results are from a single case; results may vary.


Board-certified Diplomate of the American Board of Ophthalmology and fellowship-trained retina specialist. Dr. Miller serves as the Medical Director of the Cincinnati Eye Institute.

Academic affiliations:
  • MD/PhD at the Ohio State University College of Medicine — graduated with recognition for academic excellence an national awards for his research contributions
  • Internship at Riverside Methodist Hospital in Columbus, Ohio
  • Ophthalmology residency and subspecialty training at the Bascom Palmer Eye Institute associated with the University of Miami School of Medicine


Patient Profile 1
Sex: Female
Age: 68
Diagnosis: DME
Treated Eye: OD
Concomitant conditions:
  • High blood pressure
Treatment history:
2X Focal laser
14X Anti-VEGF
1X Corticosteroid
Notes:
Phakic to pseudophakic

Reasons Dr. Miller chose ILUVIEN:
  • Multiple prior lasers and intravitreal injections without consistent control of swelling in the macula
  • Patient concern about frequent injections and results that were not optimal
  • Looking for a longer-acting treatment option


Retinal Thickness (µm)
Retinal Thickness
Best Corrected Visual Acuity (BCVA)
Best Corrected Visual Acuity
IOP: Intraocular Pressure
Intraocular Pressure


Patient Results
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg:

Patient Outcome
  • After nearly 1 year of follow-up, no additional treatments for DME were administered despite 17 prior treatments
  • Visual acuity improved
  • Good changes in optical coherence tomography (OCT)
Selected OCT Scans
References:
1. Data on File. Alimera Sciences, Inc.



"Since the patient's ILUVIEN treatment, she has been extremely pleased, her visits are far less frequent than before ILUVIEN, and she does quite well with her vision."
— Dr. Miller